The Director leads the medical content strategy and delivery for sparsentan, ensuring scientific accuracy and alignment with global medical objectives. They oversee the development of strategic content, manage cross-functional teams, and collaborate with internal and external stakeholders to translate evidence into impactful communications.
The Director of Clinical Science will manage and support nephrology development programs, overseeing clinical trial design, execution, and data analysis. They will also lead the preparation of clinical reports and regulatory submissions while maintaining relationships with key opinion leaders and alliance partners.
The Access & Reimbursement Manager serves as a subject matter expert providing education and case-specific support to healthcare providers and internal teams regarding the FILSPARI onboarding process. They proactively manage patient access barriers, coordinate with specialty pharmacies and hubs, and identify regional reimbursement trends to ensure efficient patient therapy access.
The Executive Director will lead the evaluation and execution of strategic transactions, including M&A and in-licensing, to advance the company's growth objectives. They will also partner with senior leadership to develop corporate strategy and manage cross-functional teams through the full deal lifecycle.
The Flex MSL provides proactive field medical support and scientific exchange with community nephrologists and advanced practice practitioners. They are responsible for managing KOL relationships, delivering medical presentations, and contributing to medical project support within their designated region.
The Flex MSL provides proactive field medical support and scientific exchange with community nephrologists and advanced practice practitioners. They are responsible for managing KOL relationships, delivering medical presentations, and supporting medical projects within a designated region.
The Clinical Account Manager is responsible for maximizing sales of Filspari by calling on Nephrology prescribers and positioning the company as a leader in rare kidney disease. They provide educational support to healthcare professionals and assist with patient access, reimbursement, and testing procedures.
Lead the company's FP&A function, overseeing annual budgeting, long-range planning, and financial modeling to support strategic decision-making. Partner with the CFO and Executive Leadership Team to guide capital allocation and evaluate business development initiatives like M&A.
